Oakridge International Limited (OAK.AX)
AUD 0.06
(0.0%)
AUD 0.06
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 776.75 Thousand AUD | 2.85% |
| 2023 | 755.2 Thousand AUD | -6.83% |
| 2022 | 810.53 Thousand AUD | -6.18% |
| 2021 | 863.94 Thousand AUD | -29.3% |
| 2020 | 1.22 Million AUD | -52.91% |
| 2019 | 2.59 Million AUD | 25.0% |
| 2018 | 2.07 Million AUD | -58.54% |
| 2017 | 5 Million AUD | 196.98% |
| 2016 | 1.68 Million AUD | 333.24% |
| 2015 | 389.13 Thousand AUD | -5.31% |
| 2014 | 410.96 Thousand AUD | -29.93% |
| 2013 | 586.53 Thousand AUD | 10.97% |
| 2012 | 528.55 Thousand AUD | -23.29% |
| 2011 | 688.99 Thousand AUD | -75.04% |
| 2010 | 2.76 Million AUD | 95.39% |
| 2009 | 1.41 Million AUD | 276.01% |
| 2008 | 375.75 Thousand AUD | -47.68% |
| 2007 | 718.14 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 692.64 Thousand AUD | 0.0% |
| 2024 FY | 776.75 Thousand AUD | 2.85% |
| 2024 Q4 | 776.75 Thousand AUD | 0.0% |
| 2023 Q4 | 755.2 Thousand AUD | 0.0% |
| 2023 Q2 | 832.51 Thousand AUD | 0.0% |
| 2023 FY | 755.2 Thousand AUD | -6.83% |
| 2022 Q4 | 810.53 Thousand AUD | 0.0% |
| 2022 Q2 | 780.06 Thousand AUD | 0.0% |
| 2022 FY | 810.53 Thousand AUD | -6.18% |
| 2021 Q2 | 773.69 Thousand AUD | 0.0% |
| 2021 Q4 | 863.94 Thousand AUD | 0.0% |
| 2021 FY | 863.94 Thousand AUD | -29.3% |
| 2020 FY | 1.22 Million AUD | -52.91% |
| 2020 Q2 | 810.31 Thousand AUD | 0.0% |
| 2020 Q4 | 1.22 Million AUD | 0.0% |
| 2019 Q2 | 906.92 Thousand AUD | 0.0% |
| 2019 FY | 2.59 Million AUD | 25.0% |
| 2019 Q4 | 2.59 Million AUD | 0.0% |
| 2018 FY | 2.07 Million AUD | -58.54% |
| 2018 Q4 | 2.07 Million AUD | 0.0% |
| 2018 Q2 | 1.77 Million AUD | 0.0% |
| 2017 Q4 | 5 Million AUD | 0.0% |
| 2017 Q2 | 6.89 Million AUD | 0.0% |
| 2017 FY | 5 Million AUD | 196.98% |
| 2016 Q4 | 1.68 Million AUD | 22.57% |
| 2016 Q1 | - AUD | -100.0% |
| 2016 Q3 | 1.37 Million AUD | 0.0% |
| 2016 FY | 1.68 Million AUD | 333.24% |
| 2015 Q4 | 389.13 Thousand AUD | 0.0% |
| 2015 FY | 389.13 Thousand AUD | -5.31% |
| 2014 FY | 410.96 Thousand AUD | -29.93% |
| 2014 Q4 | 410.96 Thousand AUD | 0.0% |
| 2013 FY | 586.53 Thousand AUD | 10.97% |
| 2013 Q4 | 586.53 Thousand AUD | 0.0% |
| 2012 Q4 | 528.55 Thousand AUD | 0.0% |
| 2012 FY | 528.55 Thousand AUD | -23.29% |
| 2011 Q4 | 688.99 Thousand AUD | 0.0% |
| 2011 FY | 688.99 Thousand AUD | -75.04% |
| 2010 FY | 2.76 Million AUD | 95.39% |
| 2010 Q4 | 2.76 Million AUD | 0.0% |
| 2009 FY | 1.41 Million AUD | 276.01% |
| 2009 Q4 | 1.41 Million AUD | 0.0% |
| 2008 Q4 | 375.75 Thousand AUD | 0.0% |
| 2008 FY | 375.75 Thousand AUD | -47.68% |
| 2007 FY | 718.14 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alcidion Group Limited | 27.52 Million AUD | 97.178% |
| Artrya Limited | 2.2 Million AUD | 64.821% |
| Beamtree Holdings Limited | 12.51 Million AUD | 93.794% |
| Cogstate Limited | 25.32 Million AUD | 96.933% |
| Careteq Limited | 3.29 Million AUD | 76.427% |
| Doctor Care Anywhere Group PLC | 32.27 Million AUD | 97.593% |
| Emyria Limited | 3 Million AUD | 74.111% |
| Global Health Limited | 5.97 Million AUD | 87.004% |
| HITIQ Limited | 5.2 Million AUD | 85.066% |
| Intelicare Holdings Limited | 1.68 Million AUD | 53.905% |
| ImExHS Limited | 6.66 Million AUD | 88.354% |
| Mach7 Technologies Limited | 21.17 Million AUD | 96.332% |
| MedAdvisor Limited | 47.19 Million AUD | 98.354% |
| Opyl Limited | 501.75 Thousand AUD | -54.806% |
| PainChek Limited | 2.89 Million AUD | 73.139% |
| Pro Medicus Limited | 69.69 Million AUD | 98.886% |
| Resonance Health Limited | 9.35 Million AUD | 91.694% |
| Singular Health Group Ltd | 909.58 Thousand AUD | 14.604% |
| Total Brain Limited | 4.43 Million AUD | 82.504% |